Article
First Week HCV RNA Level Under the Pegylated Interferon and Ribavirin Treatment Predicts Sustained Virological Response.
American journal of therapeutics - 1 Jan 2000
Bayram Mehmet, Koksal Ali Riza, Alkim Huseyin, Boga Salih, Ergun Meltem, Ozdogan Osman, Altinkaya Engin, Alkim Canan
Abstract excerpt
This study was planned to investigate whether the decrease in the hepatitis C virus (HCV) RNA levels at the first week of combined pegylated interferon and ribavirin treatment of naive genotype 1 patients with HCV was predicting sustained virologic response (SVR). Fifty-two patients were enrolled into the study. HCV RNA levels were measured at the baseline, first, fourth, and 12th weeks of treatment. Thirty-four...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.